Kits Eyecare Ltd.Kits Eyecare Ltd.Kits Eyecare Ltd.

Kits Eyecare Ltd.

No trades
No trades

Price target

22.930.000.00%
The 7 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings in the past 3 months.

EPS

Reported
Estimate
Metrics
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Metrics
Reported
Estimate
Surprise
Disclaimer

Frequently asked questions


The current price of KITS is 15.44 CAD — it has increased by 3.55% in the past 24 hours. Watch Kits Eyecare Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange Kits Eyecare Ltd. stocks are traded under the ticker KITS.
KITS stock has risen by 1.65% compared to the previous week, the month change is a 6.93% rise, over the last year Kits Eyecare Ltd. has showed a −1.28% decrease.
We've gathered analysts' opinions on Kits Eyecare Ltd. future price: according to them, KITS price has a max estimate of 26.50 CAD and a min estimate of 19.00 CAD. Watch KITS chart and read a more detailed Kits Eyecare Ltd. stock forecast: see what analysts think of Kits Eyecare Ltd. and suggest that you do with its stocks.
KITS reached its all-time high on Jan 15, 2026 with the price of 22.56 CAD, and its all-time low was 1.97 CAD and was reached on May 9, 2022. View more price dynamics on KITS chart.
See other stocks reaching their highest and lowest prices.
KITS stock is 4.77% volatile and has beta coefficient of 1.61. Track Kits Eyecare Ltd. stock price on the chart and check out the list of the most volatile stocks — is Kits Eyecare Ltd. there?
Today Kits Eyecare Ltd. has the market capitalization of ‪507.03 M‬, it has decreased by −2.64% over the last week.
Yes, you can track Kits Eyecare Ltd. financials in yearly and quarterly reports right on TradingView.
Kits Eyecare Ltd. is going to release the next earnings report on Nov 11, 2026. Keep track of upcoming events with our Earnings Calendar.
KITS earnings for the last quarter are 0.06 CAD per share, whereas the estimation was 0.03 CAD resulting in a 72.03% surprise. The estimated earnings for the next quarter are 0.05 CAD per share. See more details about Kits Eyecare Ltd. earnings.
Kits Eyecare Ltd. revenue for the last quarter amounts to ‪58.43 M‬ CAD, despite the estimated figure of ‪58.25 M‬ CAD. In the next quarter, revenue is expected to reach ‪62.99 M‬ CAD.
KITS net income for the last quarter is ‪1.46 M‬ CAD, while the quarter before that showed ‪1.98 M‬ CAD of net income which accounts for 0.00% change. Track more Kits Eyecare Ltd. financial stats to get the full picture.
No, KITS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 15, 2026, the company has 176 employees. See our rating of the largest employees — is Kits Eyecare Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kits Eyecare Ltd. EBITDA is ‪10.72 M‬ CAD, and current EBITDA margin is 5.26%. See more stats in Kits Eyecare Ltd. financial statements.
Like other stocks, KITS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kits Eyecare Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kits Eyecare Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kits Eyecare Ltd. stock shows the buy signal. See more of Kits Eyecare Ltd. technicals for a more comprehensive analysis.